Menu

Megan Ji practices general corporate and securities law and represents public and emerging growth companies in a broad range of industries. She has experience with Securities and Exchange Commission periodic reporting and disclosure obligations, IPOs and other public offerings, private financings and general counseling.

Download full bio 

Experience

  • AN2 Therapeutics – $79 Million IPO 

  • Rani Therapeutics – $73 Million IPO 

  • Dynavax Technologies – $200 Million Convertible Notes Offering 

Education

  • Columbia Law School
    JD, James Kent Scholar, Harlan Fiske Stone Scholar, 2018

  • Dartmouth College
    AB, Economics, East Asian Studies
    cum laude, 2012


Admissions & Credentials

New York

Washington

Media & Insight